Plasma half-lives of native and modified insulin-like growth factor-I in lambs
- 1 May 1988
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 117 (2) , 183-189
- https://doi.org/10.1677/joe.0.1170183
Abstract
The clearance of labelled insulin-like growth factor-I (IGF-I) has been measured in lambs following acid gel-permeation chromatography and immunoprecipitation of plasma samples. The half-lives obtained in three experiments were between 5 and 7 h. Chromatography at neutral pH on a Fractogel HW55(S) column demonstrated that all the radioactivity associated with undegraded peptide in plasma was bound to a carrier protein. Similar studies with IGF-I that had been reduced by prior dithiothreitol treatment showed that two-thirds of the initial radioactivity in plasma decayed with a much shorter half-life and represented material that did not bind to carrier proteins in plasma. The remaining radioactivity was both associated with a binding protein and exhibited the characteristically long half-life of the native growth factor. Analysis of plasma samples using reversed-phase chromatography demonstrated that the radioactive component with a long half-life was IGF-I while that with a short half-life had been reoxidized to an incorrect form of the growth factor. When reoxidation of reduced IGF-I was blocked by S-carboxymethylation before injection of the radioactive peptide into lambs, it remained unbound in plasma and had a 0·8–0·9 h half-life. We suggest that reduced IGF-I only associates with the binding protein upon oxidation and correct folding and that this association is necessary in order for IGF-I to have a relatively long half-life. J. Endocr. (1988) 117, 183–189This publication has 15 references indexed in Scilit:
- Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrumBiochemical Journal, 1986
- Synthesis of an insulin-like compound consisting of the A chain of insulin and a B chain corresponding to the B domain of human insulin-like growth factor IBiochemistry, 1985
- Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure.Journal of Clinical Investigation, 1985
- Expression of a biologically active analogue of somatomedin-C/insulin-like growth factor IGene, 1985
- Synthesis and characterization of molecular hybrids of insulin and insulin-like growth factor I. The role of the A-chain extension peptide.Journal of Biological Chemistry, 1982
- Development of a heterologous radioimmunoassay for somatomedin C in sheep bloodJournal of Endocrinology, 1982
- The Somatomedin C Binding Protein: Evidence for a Heterologous Subunit Structure*Journal of Clinical Endocrinology & Metabolism, 1980
- GROWTH-HORMONE DEPENDENCE OF NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY (NSILA) AND OF NSILA-CARRIER PROTEIN IN RATSActa Endocrinologica, 1978
- Demonstration of a Specific Serum Carrier Protein of Nonsuppressible Insulin-like Activity in Vivo*Journal of Clinical Endocrinology & Metabolism, 1977
- THE SERUM HALF-LIFE OF SOMATOMEDIN ACTIVITY: EVIDENCE FOR GROWTH HORMONE DEPENDENCEActa Endocrinologica, 1976